Patents by Inventor Zhibin MENG

Zhibin MENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma
    Patent number: 11583508
    Abstract: Disclosed is a use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament for treating lymphoma, wherein the lymphoma is preferably non-Hodgkin's lymphoma, further preferably aggressive non-Hodgkin's lymphoma, more preferably diffuse large B-cell lymphoma or peripheral T-cell lymphoma, and more further preferably relapsed or refractory diffuse large B-cell lymphoma or peripheral T-cell lymphoma. The mitoxantrone liposomes are used as single anti-tumor therapeutic agent without being combined with other anti-tumor agents.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: February 21, 2023
    Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
    Inventors: Chunlei Li, Yueying Peng, Kun Lou, Yajuan Wang, Yumei Wang, Shan Chen, Zhibin Meng, Jianfei Xue, Jing Yuan, Hongmei Luo, Xuekun Yao, Shixia Wang
  • USE OF MITOXANTRONE LIPOSOME FOR TREATING NON-HODGKIN'S LYMPHOMA
    Publication number: 20210267915
    Abstract: Disclosed is a use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament for treating lymphoma, wherein the lymphoma is preferably non-Hodgkin's lymphoma, further preferably aggressive non-Hodgkin's lymphoma, more preferably diffuse large B-cell lymphoma or peripheral T-cell lymphoma, and more further preferably relapsed or refractory diffuse large B-cell lymphoma or peripheral T-cell lymphoma. The mitoxantrone liposomes are used as single anti-tumor therapeutic agent without being combined with other anti-tumor agents.
    Type: Application
    Filed: July 10, 2019
    Publication date: September 2, 2021
    Inventors: Chunlei LI, Yueying PENG, Kun LOU, Yajuan WANG, Yumei WANG, Shan CHEN, Zhibin MENG, Jianfei XUE, Jing YUAN, Hongmei LUO, Xuekun YAO, Shixia WANG